Epstein Secrets

r Dodon in a presidential election run-off in Moldova on Sunday. Dodon "said he remained optimistic of victory, despite partial results which showed Sandu on 51.3% of votes compared to 48.67 for Dodon, with 91.6% of ballots counted." Dodon, "who on Friday had called on supporters to take to the street

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

r Dodon in a presidential election run-off in Moldova on Sunday. Dodon "said he remained optimistic of victory, despite partial results which showed Sandu on 51.3% of votes compared to 48.67 for Dodon, with 91.6% of ballots counted." Dodon, "who on Friday had called on supporters to take to the street

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

r Dodon in a presidential election run-off in Moldova on Sunday. Dodon "said he remained optimistic of victory, despite partial results which showed Sandu on 51.3% of votes compared to 48.67 for Dodon, with 91.6% of ballots counted." Dodon, "who on Friday had called on supporters to take to the street

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying